Nutraceutical Reports Q3 Results($146402 Liabilities and Stockholders'...),Health

Liabilities and Stockholders' Equity

Current liabilities $18,123 $20,275

Long-term liabilities 30,923 20,208

Stockholders' equity 112,877 105,919

$161,923 $146,402

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited; dollars in thousands, except per share data)

Three months Nine months

ended June 30, ended June 30,

2008 2007 2008 2007

Net sales $40,454 $38,694 $125,986 $116,646

Cost of sales 18,489 17,889 57,192 53,193

Gross profit 21,965 20,805 68,794 63,453

Operating expenses

Selling, general and

administrative 16,933 15,730 50,539 45,688

Amortization of

intangible assets 185 121 522 230

Income from operations 4,847 4,954 17,733 17,535

Interest and other

(income)/expense, net 223 352 1,008 814

Income before provision

for income taxes 4,624 4,602 16,725 16,721

Provision for income taxes 1,771 1,749 6,309 6,354

Net income $2,853 $2,853 $10,416 $10,367

Net income per common share

Basic $0.26 $0.26 $0.94 $0.94

Diluted 0.26 0.25 0.93 0.92

Weighted average common

shares
'/>"/>